Search Results

Suggested Topics within your search.
Refine Results
  1. 1
    ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial

    ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial by Jeffrey A. Lieberman, Robert E. Davis, Christoph U. Correll, Donald Goff, John M. Kane, Carol A. Tamminga, Sharon Mates, Kimberly E. Vanover

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile

    Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile by Ozan Pazvantoğlu, Şahabettin Selek, İhsan Tuncer Okay, Cem Şengül, Koray Karabekiroğlu, Nesrin Dılbaz, Özcan Erel

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Omega-3 Fatty Acid Supplementation in Adolescents with Borderline Personality Disorder and Ultra-High Risk Criteria for Psychosis: A Post Hoc Subgroup Analysis of a Double—Blind, Randomized Controlled Trial

    Omega-3 Fatty Acid Supplementation in Adolescents with Borderline Personality Disorder and Ultra-High Risk Criteria for Psychosis: A Post Hoc Subgroup Analysis of a Double—Blind, R... by G. Paul Amminger, Andrew M. Chanen, Susanne Ohmann, Claudia M. Klier, Nilufar Mossaheb, Andreas Bechdolf, Barnaby Nelson, Andrew Thompson, Patrick D. McGorry, Alison R. Yung, Miriam R. Schäfer

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

    Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia by Richard S.E. Keefe, Herbert Meltzer, Nancy Dgetluck, Maria S. Gawryl, Gerhard Koenig, Hans J. Moebius, Ilise Lombardo, Dana Hilt

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Reduced left uncinate fasciculus fractional anisotropy in deficit schizophrenia but not in non‐deficit schizophrenia

    Reduced left uncinate fasciculus fractional anisotropy in deficit schizophrenia but not in non‐deficit schizophrenia by Ömer Kitiş, Özgün Özalay, E. Burcak Zengin, Damla İşman Haznedaroğlu, Çağdaş Eker, Dilek Yalvaç, Kaya Oğuz, Kerry L. Coburn, Ali Saffet Gönül

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation

    Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation by Dorota Frydecka, Błażej Misiak, Edyta Pawlak, Lidia Karabon, Anna Tomkiewicz, P Sedlaczek, Andrzej Kiejna, Jan Aleksander Beszłej

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Improvement of schizophrenia with electroconvulsive therapy and serum brain‐derived neurotrophic factor levels: Lack of association in a pilot study

    Improvement of schizophrenia with electroconvulsive therapy and serum brain‐derived neurotrophic factor levels: Lack of association in a pilot study by Brisa S. Fernandes, Raffael Massuda, Mariana Torres, Daniel Camargo, Gabriel R. Fries, Clarissa Severino Gama, Paulo Belmonte‐de‐Abreu, Flávio Kapczinski, Maria Inês Rodrigues Lobato

    Published 2010
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  8. 8
    Structured Walking and Chronic Institutionalized Schizophrenia Inmates: A pilot RCT Study on Quality of Life

    Structured Walking and Chronic Institutionalized Schizophrenia Inmates: A pilot RCT Study on Quality of Life by Siew Yim Loh, Amalina Abdullah, Abdul Kadir Abu Bakar, Thambu Maniam, Nik Ruzyanei Nik Jaafar

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Yoga in schizophrenia: a systematic review of randomised controlled trials

    Yoga in schizophrenia: a systematic review of randomised controlled trials by Davy Vancampfort, Kristof Vansteelandt, Thomas W. Scheewe, Michel Probst, Jan Knapen, Amber De Herdt, Marc D. Binder

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms

    Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms by Małgorzata Urban‐Kowalczyk, Janusz Śmigielski, Justyna Pigońska

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Transcranial Magnetic Stimulation for Schizophrenia

    Transcranial Magnetic Stimulation for Schizophrenia by Nadine Dougall, Nicola Maayan, Karla Soares‐Weiser, Lisa McDermott, Andrew M. McIntosh

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Pain Perception in Schizophrenia: Evidence of a Specific Pain Response Profile

    Pain Perception in Schizophrenia: Evidence of a Specific Pain Response Profile by Mylène Lévesque, Stéphane Potvin, Serge Marchand, Émmanuel Stip, Sylvain Grignon, Pierre Lalonde, Olivier Lipp, Philippe Goffaux

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia

    Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia by Dieter Naber, Karina Hansen, Carlos Forray, Ross A. Baker, Christophe Sapin, Maud Beillat, Timothy Peters-Strickland, Anna‐Greta Nylander, P. Hertel, Henrik Steen Andersen, Anna Eramo, Jean‐Yves Loze, Steven G. Potkin

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes

    A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes by Delbert G. Robinson, Juan A. Gallego, Majnu John, Georgios Petrides, Youssef Hassoun, Jianping Zhang, Leonardo Lopez, Raphael J. Braga, Serge Sevy, Jean Addington, Charles H. Kellner, Mauricio Tohen, Melissa Naraine, Natasha Bennett, Jessica Greenberg, Todd Lencz, Christoph U. Correll, John M. Kane, Anil K. Malhotra

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Acetylcholinesterase inhibitors for schizophrenia

    Acetylcholinesterase inhibitors for schizophrenia by Jasvinder A. Singh, Kamalpreet Kour, Mahesh Jayaram

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study

    Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study by Mengxin Wang, Ruihua Hou, Jian Jia, Guolin Mi, Hui-Min Qiu, Bingyu Cao, Tang Mao-qin

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    The Beck Cognitive Insight Scale in Outpatients with Psychotic Disorders: Further Evidence from a French-Speaking Sample

    The Beck Cognitive Insight Scale in Outpatients with Psychotic Disorders: Further Evidence from a French-Speaking Sample by Jérôme Favrod, Grégoire Zimmermann, Stéphane Raffard, Valentino Pomini, Yasser Khazaal

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    North American Prodrome Longitudinal Study (NAPLS 2)

    North American Prodrome Longitudinal Study (NAPLS 2) by Jean Addington, Lu Liu, Lisa Buchy, Kristin S. Cadenhead, Tyrone D. Cannon, Barbara A. Cornblatt, Diana O. Perkins, Larry J. Seidman, Ming T. Tsuang, Elaine F. Walker, Scott W. Woods, Carrie E. Bearden, Daniel H. Mathalon, Thomas H. McGlashan

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia

    Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia by Karena Meehan

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables

    A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables by Dieter Naber

    Published 1995
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: